Publications

Below you find the latest publications on PubMed that discuss the FinnDiane cohort. For a complete overview click here

• Comparison of Serum Creatinine- and Cystatin C-Based eGFR at Baseline and Their Prediction of Incident Moderate Albuminuria in Individuals With Type 1 Diabetes
  02.04.2025 by Valma Harjutsalo
  CONCLUSIONS: These findings suggest SCysC may facilitate early identification of individuals at risk for albuminuria.
• Progression of Cerebral Small Vessel Disease Among Neurologically Asymptomatic Middle-Aged Individuals With Type 1 Diabetes
  17.03.2025 by Aleksi Tarkkonen
  CONCLUSIONS: The prevalence of CSVD doubled over a 7.5-year period in middle-aged individuals with type 1 diabetes.
• Correction: Excessive occupational sitting increases risk of cardiovascular events among working individuals with type 1 diabetes in the prospective Finnish Diabetic Nephropathy Study
  18.01.2025 by Matias Seppälä
  No abstract
• Genome-wide characterization of 54 urinary metabolites reveals molecular impact of kidney function
  02.01.2025 by Erkka Valo
  Dissecting the genetic mechanisms underlying urinary metabolite concentrations can provide molecular insights into kidney function and open possibilities for causal assessment of urinary metabolites with risk factors and disease outcomes. Proton nuclear magnetic resonance metabolomics provides a high-throughput means for urinary metabolite profiling, as widely applied for blood biomarker studies. Here we report a genome-wide […]
• Urinary metabolomics provide insights into coronary artery disease in individuals with type 1 diabetes
  27.11.2024 by Anni A Antikainen
  CONCLUSIONS: We have performed the first high-throughput urinary metabolomics analysis on CAD in individuals with type 1 diabetes and found xanthosine, 3-hydroxyisobutyrate, trans-aconitate, and 4-deoxythreonate to be associated with incident CAD. In addition, metabolomic state profiling improved prediction of incident CAD.